Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
Recruitment status was Active, not recruiting
The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.
|Study Design:||Allocation: Randomized
Masking: Single Blind
Primary Purpose: Treatment
|Official Title:||Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline|
- safety of selegiline
- pharmacokinetic assessment
|Study Start Date:||September 2001|
|Estimated Study Completion Date:||October 2002|
To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.
|United States, California|
|UCLA Integrated Substance Abuse Program|
|Los Angeles, California, United States, 90024|
|Principal Investigator:||Thomas Newton, M.D.||University of California, Los Angeles|